PODD Insulet margins

Relative Growth: Rel. Growth: 99

Relative Strength: Rel. Strength: 29

Relative Valuation: Rel. Valuation: 64

Relative Profitability: Rel. Profitability: 95

Gross margin

71.9%

Operating margin

18.4%

EBITDA margin

22.4%

Net margin

13.4%

For the latest period, Insulet has a gross margin of 71.9%, an operating margin of 18.4%, an EBITDA margin of 22.4%, and a net margin of 13.4%. All measured margins increased year over year, led by EBITDA margin with an increase of 4.5 percentage points.

PODD margin history

Gross, operating, EBITDA and net margin trends

Insulet's margins averaged 70.3% gross, 16.03% operating, 19.7% EBITDA, and 14.26% net during the last 3 years. At present, gross, operating, and EBITDA margins are above their three-year averages, while net margin is below its three-year average.

PODD margin expansion

Year-over-year margin changes in percentage points

All available margins expanded year over year, led by EBITDA margin with an increase of 4.5 percentage points.

Gross margin expansion

0.4pp

Operating margin expansion

1.1pp

EBITDA margin expansion

4.5pp

Net margin expansion

3.6pp

PODD Gross margin

Over the last 3 years, Insulet's gross margin averaged 70.3%. At present, Insulet's current gross margin is 71.9%, which is 1.6 percentage points above its three-year average. During this period, gross margin reached a high of 71.9% in Sep 2026 and a low of 68.3% in Dec 2023.

PODD Operating margin

Throughout the last 3 years, Insulet had an average operating margin of 16.03%. Against its three-year average, Insulet's operating margin is currently 18.4%, 2.4 percentage points above its three-year average. Looking back over the last 3 years, Insulet's operating margin reached 18.4% at its highest point in Sep 2026 and 13% at its lowest in Dec 2023.

PODD EBITDA margin

Insulet's EBITDA margin averaged 19.7% over the last 3 years. Compared with its three-year average, Insulet's current EBITDA margin is 22.4% and is 2.7 percentage points above its three-year average. Over the last 3 years, Insulet's EBITDA margin peaked at 22.4% in Sep 2026 and reached a low of 17.3% in Jun 2025.

PODD Net margin

Over the last 3 years, Insulet's net margin averaged 14.26%. Currently, Insulet's current net margin is 13.4%, which is 0.9 percentage points below its three-year average. During this period, net margin reached a high of 21.2% in Sep 2024 and a low of 9.1% in Dec 2025.

PODD margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 71.9%, PODD is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 68.3%, Insulet's gross margin is 5% higher.

PODD margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Insulet's gross margin?

As of Sep 30, 2026, PODD has a gross margin of 71.9%.

What is Insulet's operating margin?

As of Sep 30, 2026, PODD has an operating margin of 18.4%.

What is Insulet's EBITDA margin?

The current EBITDA margin for PODD is 22.4% as of Sep 30, 2026.

What is Insulet's net margin?

The current net margin for PODD is 13.4% as of Sep 30, 2026.

What are the average margins of PODD?

Insulet's gross, operating, EBITDA, and net margins averaged 70.3% gross, 16.0% operating, 19.7% EBITDA, and 14.3% net over the last 3 years.

What are the highest historical margins of PODD?

Insulet's highest recorded margins during the past 5 years were 71.9% gross in Sep 2026, 18.4% operating in Sep 2026, 22.4% EBITDA in Sep 2026, and 21.2% net in Sep 2024.

What are the lowest historical margins of PODD?

Looking back across 5 years, PODD reached its lowest margins at 61.1% gross in Mar 2023, 2% operating in Mar 2023, 7.7% EBITDA in Mar 2023, and 0% net in Mar 2023.